Chemomab Therapeutics Ltd...

AI Score

0

Unlock

2.05
-0.03 (-1.44%)
At close: Jan 28, 2025, 3:00 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY12
PE Ratio -4.95 -26.34 -114.02 -173.17 -28.36 -158.22 -15.9 -198.38 -104.91 4.29
PS Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio 7.05 20.11 23.29 95.07 51.75 222.66 -256.08 285.13 366.86 31.55
P/FCF Ratio -5.07 -35.63 -113.5 -194.49 -46.46 -151.23 -18.24 -247.17 -105.36 n/a
P/OCF Ratio -5.08 -35.75 -115.69 -195.9 -46.73 -153.49 -18.31 -252.2 -106.61 n/a
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.02 0.01 0.01 0.04 0.07 n/a n/a n/a n/a n/a
Quick Ratio 4.32 6.18 41.58 9.50 4.42 4.00 0.59 2.07 2.32 1.87
Current Ratio 4.32 6.18 23.66 9.00 4.42 3.98 0.59 2.07 2.32 1.87
Asset Turnover n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -80.83 -111.64 -995.33 -2.18K n/a -1.88K n/a -503.81 n/a
Return on Equity (ROE) -1.43 -0.76 -0.2 -0.55 -1.83 -1.41 16.10 -1.44 -3.5 7.35
Return on Assets (ROA) -1.09 -0.64 -0.2 -0.48 -1.38 -1.08 -4.7 -0.84 -2.13 2.55
Return on Capital (ROIC) -1.47 -0.79 -0.2 -0.54 -1.25 -1.3 15.42 -1.41 -3.27 5.26
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a